Pet industry M&A picks up again across food, distribution, and services
The pet industry’s winter M&A wave is broadening beyond isolated transactions into a more visible consolidation pattern across food, distribution, and services. Recent deals include AlphaPet Ventures’ March 27, 2026 acquisition of Belgian premium pet food brand Cpro Food, as well as the February 18, 2026 agreement to merge Covetrus with MWI Animal Health. Together with Blackstone’s $2.3 billion acquisition of Rover, the activity suggests that strategic buyers and private capital still see pet care as a sector worth building around, even after the post-pandemic growth surge cooled. (webdisclosure.com)
The backdrop is a pet market that remains attractive, but more selective. S&P Global Market Intelligence reported that private equity and venture capital investment in pet care, food, and supplies jumped 659% year over year in 2023, reaching $2.89 billion, the highest annual announced value since 2019. More recent market commentary suggests momentum continued through 2025, with dealmakers focusing on categories that offer either premiumization, recurring revenue, or operational scale. Capstone Partners said sentiment pointed to a rebound in 2026, particularly where consolidation could improve margins or strengthen services niches. (spglobal.com)
AlphaPet’s latest move fits that pattern closely. In its announcement, the company said Cpro Food gives it access to Belgium, which it described as one of Europe’s pet food markets with the highest premium share. AlphaPet also framed the deal as another step in its “local hero” strategy, adding a brand founded in 2014 with distribution through specialty retailers and breeders. That matters because many of the current pet-food deals aren’t about global scale alone; they’re about assembling premium regional brands that already have loyal demand and can be plugged into larger digital and retail distribution systems. (webdisclosure.com)
The Covetrus-MWI transaction is more directly relevant to veterinary medicine. Cencora said the merger would create a combined animal-health platform, and disclosed that the deal values MWI at $3.5 billion. Under the announced structure, Cencora would receive $1.25 billion in cash, $800 million of preferred equity, and retain a 34.3% non-controlling common equity stake in the combined company. The companies said the rationale is to combine MWI’s distribution strength with Covetrus’ technology, pharmacy, and practice-facing services. If completed as described, that would further concentrate capabilities that many clinics depend on every day. (investor.cencora.com)
Industry reaction has been consistent with a platform-building narrative. In the AlphaPet announcement, CEO Marco Hierling said Cpro Food “fits perfectly” into the company’s portfolio as a Belgian super-premium brand, while investor capiton highlighted AlphaPet’s five acquisitions in six years as evidence of a sustained integration strategy. Blackstone made a similar case when it announced Rover’s acquisition in late 2023, saying the company had meaningful runway as pet parents place a premium on convenience and high-quality care. Blackstone later told investors that the Rover acquisition closed in the first quarter of 2024. (webdisclosure.com)
Why it matters: For veterinary professionals, the bigger story is that consolidation is no longer confined to one corner of the pet economy. Distribution, pharmacy, software, nutrition, and consumer services are increasingly being assembled into larger operating ecosystems. That can produce real benefits, including broader product access, tighter logistics, and more connected tools for clinics and pet parents. But it can also reduce the number of major counterparties practices negotiate with, especially when distributors, service platforms, and technology vendors become more closely linked. Based on the deal rationales companies are publicly emphasizing, the market is rewarding businesses that can own more of the care journey, from product fulfillment to client communication to home delivery. That’s an inference, but it’s well supported by the strategic language in the Covetrus-MWI and Rover transactions, and by broader M&A analysis focused on services, premium nutrition, and science-backed pet categories. (investor.cencora.com)
There’s also a practical implication for clinics: supplier relationships may keep changing. As companies merge, veterinary teams may see shifts in account structures, software integrations, formulary breadth, fulfillment options, and pricing leverage. In some cases, that could simplify operations. In others, it may narrow flexibility. For practices already juggling staffing pressure and margin sensitivity, those back-end changes can matter as much as headline deal value. (investor.cencora.com)
What to watch: The next question is whether these winter deals remain isolated or become the start of a heavier 2026 cycle. Watch for additional acquisitions in premium pet nutrition, further distribution-and-tech combinations, and evidence that private equity and strategic buyers are still prioritizing pet services with recurring revenue or strong digital engagement. For veterinary professionals, the key signal won’t just be who buys whom, but whether those combinations materially change how clinics source products, manage workflows, and serve pet parents. (imap.com)